Skip to main content
OpenTrials
Completed

NCT Number: NCT04315844

The Trial of Ewata Balloon Guiding in the Application of Thrombectomy

To evaluate the efficacy and security of Ewata combined with a stent device in the treatment of acute ischemic stroke within 8 hours To prove whether the clinical efficacy and safety of Ewata r is not inferior to other guidings.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beijing Tiantan Hospital

Beijing, Beijing Municipality, 100000, China

About this study

This clinical trial uses multicenter, single-arm, prospective trial design,people who met the enrollment requirements were performed with Ewata balloon guiding and stent type thrombectomy device.The clinical results were compared with those of other historical guiding catheter products combined with the stent type thrombectomy device to to evaluate the clinical efficacy and safety of Ewata balloon guide catheter in combination with a stent for thrombectomy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute ischemic stroke
  • within 8 hours
  • Patients aged 18-80 years (including critical point)
  • NIHSS score 4-30 (including critical points)
  • Pre-onset mRS score <2
  • Large vessel lesions were detected by head CT, CTA, MRI, MRA, or DSA
  • The patient or his legal guardian voluntarily signs and dates a written informed 8.consent approved by the ethics committee (IBC).

Exclusion criteria

  • Head CT exclusion criteria (exclusion if any of the following conditions are met)
  • Cerebral hemorrhage
  • Intracranial tumors, except for small meningiomas
  • Large area of early cerebral infarction (low density shadow >1/3 cerebral hemisphere)

Clinical and laboratory exclusion criteria

  • seizure
  • Symptoms of nervous system loss improved rapidly
  • Severe stroke (NIHSS≥31 points) or mild stroke (NIHSS≤3 points)
  • CT examination of the skull was negative, but subarachnoid hemorrhage was not excluded from clinical symptoms
  • A history of intracranial hemorrhage and subarachnoid hemorrhage
  • A history of cranial trauma in the last 3 months
  • A history of cerebral or myocardial infarction in the last 3 months
  • A history of gastrointestinal or urinary tract bleeding in the last 3 weeks
  • A history of major surgery in the last 2 weeks
  • A history of arterial puncture in the last l weeks that was difficult to stop bleeding
  • Patients with severe cardiac, hepatic or renal insufficiency (>250 mol/L) or severe diabetes mellitus
  • Physical examination revealed evidence of active bleeding or trauma, such as a fracture
  • Oral anticoagulants have been taken, and INR>1.7
  • Blood glucose <2.7 mmol/L or >22.2 mmol/L
  • Systolic blood pressure >185 mmHg, or diastolic blood pressure >110 mmHg Pregnancy
  • There is a tendency of severe bleeding or bleeding disease, platelet count ≤80x109 /L
  • Systemic infection without control or local infection of puncture point Hypersensitivity to contrast media

Treatment and study plan

Ewata balloon guiding

Device

The balloon guide catheter is coaxial cavity and reinforced braided catheter with varying stiffness echelon.The distal end is marked by an impermeable ray, the proximal end has a bifurcated ruhr interface, and the end is embedded with a compliance balloon.The product label indicates the size of the balloon guide catheter and the maximum volume of the balloon.

Primary outcomes

  1. technical success rate of ewata

    Time frame: intraoperative

    When the balloon guiding catheter arrives at the desired location, the thrombectomy instrument can enter the balloon guiding catheter smoothly, which can be opened successfully when needed to form a local blockage of blood flow. After the thrombectomy, the thrombectomy instrument can be withdrawn back into the guide catheter, which is considered as a success.Ewata balloon guide catheter should be used at least once during thrombectomy

Secondary outcomes

  1. Rate of Vascular recanalization

    Time frame: postoperative

    TICI≥2b

  2. Rate of intraoperative adverse events

    Time frame: intraoperative

    including vascular perforation , incision,vasospasm caused by balloon guiding,balloon guide catheter rupture and other instrument-related accidents

  3. The time from the successful puncture to the expected location of ewata

    Time frame: intraoperative

    time data

  4. The time from successful puncture to recanalization

    Time frame: intraoperative

    time data,TICI≥2b

  5. Rate of symptomatic intracranial hemorrhage within 24 hours

    Time frame: 24 hours

    CT/NIHSS

  6. 24-hour mortality

    Time frame: 24-hour

    The number of all deaths reported will be recorded and adjudicated

  7. 90-day mortality

    Time frame: 90-day

    The number of all deaths reported will be recorded and adjudicated

  8. Good prognosis rate at 90 days

    Time frame: 90 days

    (mRS≤2)

  9. The thrombus escapes from the target vessel to other vessels to form new embolism

    Time frame: intraoperative

    The form of New thrombosis Judged by DSA or MRA

Sponsors and collaborators

Lead sponsor

Beijing Tiantan Hospital

Other

Registry information

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Mar 20, 2020
Registry last updated
Nov 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.